BSE filing, NSE: NEULANDLAB. Summary written from the filing by ALFA Finder's alert engine.
Neuland Laboratories Ltd: key numbers
- Share price
- ₹19,250.00
- Market cap
- ₹24,698 Cr
- Revenue (annual)
- ₹2,023 Cr
- Net profit (annual)
- ₹364.0 Cr
- P/E (TTM)
- 49.6×Sector 46.1×
- Promoter holding
- 32.26%-0.36% QoQ
- FII holding
- 21.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Neuland Laboratories Ltd
All →Neuland Laboratories Other Announcement
Neuland Laboratories notified loss of 100 share certificates by shareholder Madan Mohan Singh. The company requested issuance of an entitlement letter in lieu of the lost certificates.
Neuland Laboratories Board Meeting Date
Neuland Laboratories will hold a board meeting on November 3, 2026, to consider and approve the unaudited financial results for the quarter ended September 30, 2026.
Neuland Laboratories Business Update
Neuland Laboratories' Unit 3 manufacturing facility received an Establishment Inspection Report from the US FDA. The agency has officially closed the inspection.
Neuland Laboratories Other Announcement
Neuland Laboratories Ltd has submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI Regulation 31.
Neuland Laboratories Promoter Selling (Off-Market)
Neuland Laboratories' promoter group, Davuluri Rohini Niveditha Rao and Davuluri Saharsh Rao, completed an off-market inter-se transfer of 10,000 shares via gift.
- Promoter stake change
- +0.07%
Neuland Laboratories Production Started
Neuland commissioned its first commercial peptide manufacturing module with 7,000L reactor capacity. Module two expansion is underway to meet rising customer demand for peptide APIs.
- peptide manufacturing reactor capacity
- 7000 L
Other board meeting date announcements
All →Sigma Solve Board Meeting Date
SIGMA SOLVE LIMITED will hold a board meeting on 03 Nov 2026 to consider unaudited standalone and consolidated results for the quarter ended September 2026. Investors should await the results filing.
Siddhi Cotspin Board Meeting Date
Siddhi Cotspin will hold a board meeting on 04-Nov-2026 to consider unaudited half-yearly results. Trading window closes until 07-11-2026.
Agarwal Fortune India Board Meeting Date
Agarwal Fortune India Ltd intimated BSE of a board meeting on 04 November 2026 to consider unaudited Q2 and half-year results ended September 30, 2026. The trading window stays closed until 06 November 2026.
Latteys Industries Board Meeting Date
Latteys Industries will hold a board meeting on 5 November 2026 to consider unaudited standalone Q2 results. Trading window closes 1 October to 7 November 2026.
Binny Mills Board Meeting Date
Binny Mills will hold a board meeting on November 6, 2026 to consider unaudited standalone half-yearly results. The trading window stays closed until November 8, 2026.
Shanti Gold International Board Meeting Date
Shanti Gold will hold a board meeting on November 3, 2026 to consider unaudited results. The trading window remains closed until 48 hours after results.